Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: Is there potential for adverse events? A systematic review of the literature

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4371-4375

  Villani, Anthony M ^a   Crotty, Maria ^a   Cleland, Leslie G ^b   James, Michael J ^b   Fraser, Robert J ^a   Cobiac, Lynne ^a   Miller, Michelle D ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Adverse events; Cardiovascular disease; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Older adults

Indexed keywords

ACETYLSALICYLIC ACID; CORN OIL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 ACID ETHYL ESTER; PALM OIL; PLACEBO; PRAVASTATIN; SIMVASTATIN; SOYBEAN OIL; SUNFLOWER OIL; TRIACYLGLYCEROL; WARFARIN; FISH OIL;

BLEEDING; BLEEDING TIME; BRADYCARDIA; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL INFECTION; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MYALGIA; NAUSEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SIDE EFFECT; SKIN BRUISING; SKIN IRRITATION; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBUS; AGED; CARDIOVASCULAR DISEASES;

AGED; CARDIOVASCULAR DISEASES; FISH OILS; HUMANS; RISK FACTORS;

EID: 84886286851     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.054     Document Type: Article

References (50)

1. H.R. Knapp, I.A.G. Reilly, and P. Alessandrini In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis New Eng J Med 314 1986 937 942
2. P. Saravanan, N.C. Davidson, and E.B. Schmidt Cardiovascular effects of marine omega-3 fatty acids Lancet 376 2010 540 550
3. A.L. Farquharson, R.G. Metcalf, and P. Sanders Effect of dietary fish oil on atrial fibrillation after cardiac surgery Am J Cardiol 108 2011 851 856
4. B. Rauch, R. Schiele, and S. Schneider OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
5. R.G. Metcalf, M.J. James, and R.A. Gibson Effects of fish-oil supplementation on myocardial fatty acids in humans Am J Clin Nutr 85 2007 1222 1228
6. O. Johansen, M. Brekke, and I. Seljeflot n - 3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study J Am Coll Cardiol 33 1999 1619 1626
7. J. Eritsland, H. Arnesen, and K. Grønseth Effect of dietary supplementation with n - 3 fatty acids on coronary artery bypass graft patency Am J Cardiol 77 1996 31 36
8. G. Einvik, T.O. Klemsdal, and L. Sandvik A randomized clinical trial on n - 3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk Eur J Cardiovasc Prev Rehabil 17 2010 588 592
9. M.H. Raitt, W.E. Connor, and C. Morris Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators JAMA 293 2005 2884 2891
10. M. Yokoyama, H. Origasa, and M. Matsuzaki Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
11. G. Leng, A. Lee, and F. Fowkes Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease Clin Nutr 17 1998 265 271
12. H. Grundt, D. Nilsen, and O. Hetland Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n - 3 PUFAs in patients with an acute myocardial infarction Clin Nutr 23 2004 491 500
13. S.D. Poppitt, C.A. Howe, and F.E. Lithander Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke Stroke 40 2009 3485 3492
14. D. Green, L. Barreres, and J. Borensztajn A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients Stroke 16 1985 706 709
15. H.E. Bays Safety considerations with omega-3 fatty acid therapy Am J Cardiol 99 2007 S35 S43
16. W.S. Harris Expert opinion: omega-3 fatty acids and bleeding - cause for concern? Am J Cardiol 99 2007 S44 S46
17. M. Sugano, and F. Hirahara Polyunsaturated fatty acids in the food chain in Japan Am J Clin Nutr 71 2000 189S 196S
18. H. Iso, S. Sato, and A.R. Folsom Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men Int J Epidemiol 18 1989 374 381
19. L.G. Cleland, M.J. James, and S.M. Proudman Fish oil: what the prescriber needs to know Arthritis Res Ther 8 2006 202 208
20. E. Sydenham, A.D. Dangour, and W.S. Lim Omega 3 fatty acid for the prevention of cognitive decline and dementia Cochrane Database Systematic Reviews 6 2012 10.1002/14651858.CD005379.pub3
21. National Heart Foundation of Australia Review of the evidence: fish, fish oils, n - 3 polyunsaturated fatty acids and cardiovascular health 2008 1 7
22. C. von Schacky, and W.S. Harris Cardiovascular benefits of omega-3 fatty acids Cardiovasc Res 73 2007 310 315
23. E.M. Hjerkinn, I. Seljeflot, and I. Ellingsen Influence of long-term intervention with dietary counseling, long-chain n - 3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia Am J Clin Nutr 81 2005 583 589
24. A.S. Lindman, J.I. Pedersen, and E.M. Hjerkinn The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene Thromb Haemost 91 2004 1097 1104
25. P. Berstad, I. Seljeflot, and M.B. Veierod Supplementation with fish oil affects the association between very long-chain n - 3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1 Clin Sci 105 2003 13 20
26. A.L. Cawood, R. Ding, and F.L. Napper Eicosapentaenoic acid (EPA) from highly concentrated n - 3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability Atherosclerosis 212 2010 252 259
27. S. Nodari, M. Metra, and G. Milesi The role of n - 3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy Cardiovasc Drugs Ther 23 2009 5 15
28. J.V. Patel, K.W. Lee, J. Tomson, K. Dubb, E.A. Hughes, and G.Y. Lip Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction Int J Cardiol 115 2007 42 45
29. J.H. O'Keefe Jr., H. Abuissa, and A. Sastre Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions Am J Cardiol 97 2006 1127 1130
30. A. Geelen, I.A. Brouwer, and E.G. Schouten Effects of n - 3 fatty acids from fish on premature ventricular complexes and heart rate in humans Am J Clin Nutr 81 2005 416 420
31. T.A. Mori, R.J. Woodman, and V. Burke Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects Free Radic Biol Med 35 2003 772 781
32. R.J. Woodman, T.A. Mori, and V. Burke Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients Atherosclerosis 166 2003 85 93
33. R.J. Woodman, T.A. Mori, and V. Burke Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am J Clin Nutr 76 2002 1007 1015
34. J. Eritsland, H. Arnesen, K. Berg, I. Seljeflot, and M. Abdelnoor Serum Lp (a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n - 3 fatty acid supplementation Scand J Clin Lab Invest 55 1995 295 300
35. J. Eritsland, H. Arnesen, and I. Seljeflot Long-term metabolic effects of n - 3 polyunsaturated fatty acids in patients with coronary artery disease Am J Clin Nutr 61 1995 831 836
36. J. Eritsland, I. Seljeflot, and M. Abdelnoor Long-term effects of n - 3 fatty acids on serum lipids and glycaemic control Scand J Clin Lab Invest 54 1994 273 280
37. J. Eritsland, I. Seljeflot, and M. Abdelnoor Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids Fibrinolysis 8 1994 120 125
38. T.A. Mori, R. Vandongen, F. Mahanian, and A. Douglas Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation Metabolism 41 1992 1059 1067
39. G. Margolin, G. Huster, and C.J. Glueck Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids Am J Clin Nutr 53 1991 562 572
40. Y.K. Lungershausen, M. Abbey, and P.J. Nestel Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives J Hypertens 12 1994 1041 1046
41. M. Suzukawa, M. Abbey, and P. Howe Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages J Lipid Res 36 1995 473 484
42. R.O. Gans, H.J. Bilo, and E.G. Weersink Fish oil supplementation in patients with stable claudication Am J Surg 160 1990 490 495
43. K. Tanaka, Y. Ishikawa, and M. Yokoyama Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients subanalysis of the JELIS trial Stroke 39 2008 2052 2058
44. J. Fuchs, Y. Beigel, and P. Green Big platelets in hyperlipidemic patients J Clin Pharmacol 32 1992 639 642
45. A. Aucamp, H. Schoeman, and J. Coetzee Pilot trial to determine the efficacy of a low dose of fish oil in the treatment of angina pectoris in the geriatric patient Prostaglandins Leukot Essent Fatty Acids 49 1993 687 689
46. C.R. Sirtori, R. Paoletti, and M. Mancini n - 3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study Am J Clin Nutr 65 1997 1874 1881
47. M. Petersen, H. Pedersen, and A. Major-Pedersen Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients Diabetes Care 25 2002 1704 1708
48. F. Thies, J. Garry, and P. Yaqoob Association of n - 3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial Lancet 361 2003 477 485
49. H. Grundt, D.W. Nilsen, and M.A. Mansoor Reduction in homocysteine by n - 3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties Pathophysiol Haemost Thromb 33 2003 88 95
50. D.W. Nilsen, G. Albrektsen, and K. Landmark Effects of a high-dose concentrate of n - 3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol Am J Clin Nutr 74 2001 50 56